author-photo

Paul Foster

Genentech

13

Papers

495

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up: A Phase 1b Clinical Trial

2019 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (122)
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (52)
Abstract CT028: Atezolizumab (atezo) + nab-paclitaxel (nab-pac) in metastatic triple-negative breast cancer (mTNBC): 2-year update from a ph Ib trial

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (13)
Atezolizumab (atezo) plus platinum-based chemotherapy (chemo) in non-small cell lung cancer (NSCLC): Update from a phase Ib study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (114)
Efficacy and safety of cobimetinib (cobi) and atezolizumab (atezo) in an expanded phase 1b study of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (5)